Post by benh on May 28, 2015 15:03:41 GMT -5
app.core-apps.com/tristar_ada15/event/02e28c94f324df056418f55ce69ab3d2
[Board No. 96] Efficacy and Safety of Technosphere Inhaled Insulin: Systematic Review and Meta-analysis
app.core-apps.com/tristar_ada15/event/02e28c94f324df056418f55ce6969172
[Board No. 94] Inhalation of Insulin: Effect of Symptomatic Upper Respiratory Tract Infections on Pharmacokinetic/Pharmacodynamic (PK/PD) Properties
Previously worked for Sanofi - f1000.com/posters/browse/summary/1089301
app.core-apps.com/tristar_ada15/event/02e28c94f324df056418f55ce693b6b5
[Board No. 92] Ultra-Rapid-Acting/Basal Concentrated Insulin BIOD-531 Demonstrates Superior Postprandial Glucose Control and Potential for Flexible Post-meal Dosing Compared with Marketed Prandial/Basal Insulins in Insulin-Resistant Patients with Type 2 Diabetes
www.biodel.com/content/pipeline/concentrated-ultra-rapid-acting-insulin.htm
Abstract bodies will be available at 5pm EDT tomorrow.......
